EVGN
Evogene Ltd.
An Israeli computational biology and chemistry company in Rehovot that uses artificial intelligence to design small molecules for both farming and medicine. It was founded in 2002 as a spin-out from the computational biology firm Compugen, originally using predictive models to breed better crops, and today its ChemPass AI engine designs everything from drug candidates to agricultural chemicals. The name blends "evolution" and "gene," reflecting its early roots in plant genomics.
ISIN: IL0011050551HealthcareIL1 holder
Total Value
$3.19M
Total Shares
2.30M
Net Share Change
-650.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
